Anses-ANMV is involved with the Anses laboratories in the fight against antibiomicrobial resistance.
Since 1999, the Anses-ANMV has set up a national monitoring of the sales of veterinary medicinal products containing antibiotics. This sales survey makes it possible to evaluate the use and to monitor the evolution of antibiotic therapy practices for the various animal species. The information collected is one of the essential elements, together with the monitoring of bacterial resistance, to enable an assessment of the risks associated with antibiotic resistance. Anses-ANMV is strongly involved in the collection of antimicrobial use data, which is expected to develop rapidly with the mandatory reporting of amounts of antimicrobials delivered by veterinarians, pharmacists, manufacturers and distributors of medicated feed.
Anses-ANMV analyses the risks associated with antibiotic resistance in the context of MA procedures. The Agency is also working on the evaluation of risk practices in veterinary medicine, and possible alternatives to the use of antibiotics in livestock.
Anses-ANMV is involved in European and international groups on the collection of antimicrobial sales and use data, the assessment of the risks of the emergence of antibiotic resistance and in the analysis of the links between antibiotic uses and resistance.
Activities of the team working on antimicrobial resistance:
Monitoring of sales of antibiotic medicines by MAHs
Link to Sales survey of veterinary antibiotics in France
Transmission of sales data to EMA under ESVAC (European Surveillance of Veterinary Antimicrobial Consumption) and to the OIE
Monitoring of deliveries of antibiotics by manufacturers and distributors of medicated feed
Monitoring of FAM and DAM antibiotic sales
Monitoring of deliveries of antibiotics with Calypso
Mandatory reporting of amounts of antimicrobials delivered by veterinarians and pharmacists
Monitoring of antibiotic use in farms
Steering actions under the Ecoantibio plans
Involvement in the development of the inter-ministerial roadmap for controlling antibiotic resistance
The roadmap (PDF)
Evaluation of MA authorizations for medicinal products containing antibiotic
Involvement in the writing of scientific opinions, participation in referrals on antibiotic resistance
Collaboration with veterinarians in the writing of good practice guides for the use of antibiotics
Participation in the Antimicrobials Working Party (AWP), EMA Working Group which provides advice on matters concerning the use and authorisation of antimicrobials
Contribution to the work of the AMEG (Antimicrobial Advice Ad Hoc Expert Group) which produces opinions on request from the European Commission (Colistine, European categorisation of antibiotics)
Participation in ESVAC working groups and the establishment of the harmonised collection of data on sales and use of antimicrobial medicinal products in the framework of European legislation
Participation in JIACRA, inter-agency group (ECDC, EFSA, EMA) leading expert work for the European Commission, in particular on the link between consumption and antibiotic resistance in both veterinary and human medicine
As an OIE Collaborating Centre, participation in the OIE Permanent Working Group on Antibioresistance and International Training
Participation in the WHO Advisory Group — Critically Important Antimicrobials (AG-CIA), Codex Alimentarius via TFAMR (Task Force on Antimicrobial Resistance), FAO, etc.